Globus Medical (GMED) support and resistance · P/E 42, rev $1.55B
Globus Medical (GMED) is a medical devices company listed on US.
This page maps Globus Medical (GMED) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported GMED revenue for 2026-06-30 was $1.55B. Net income was $275.9M. GMED currently screens at market cap $7.66B and trailing P/E 42.1.
GMED currently screens at market cap $7.66B and trailing P/E 42.1. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new GMED 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the GMED quote page for the session range and the stock page for the full model.
Not investment advice.